ProShare Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Other funds holding PDLI
SPC
PWAM
GCIA
JC
GF
CCM
WG
ProShare Advisors's PDLI Position: Q4 2020 in Review
ProShare Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 32,038 shares — an estimated $101K sold.
ProShare Advisors first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $2.11M in Q1 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.
- ProShare Advisors reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
- ProShare Advisors sold 32,038 PDL BioPharma, Inc. shares in Q4 2020, an estimated $101K.
- ProShare Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
- ProShare Advisors's PDL BioPharma, Inc. position peaked at $2.11M in Q1 2014.
- 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.
Based on ProShare Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.